Glassman Wealth Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Glassman Wealth Services’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-169	Closed	-$1.93K	–	990
2023 Q4	$1.93K	Hold	169	–	–	﹤0.01%	1359
2023 Q3	$1.63K	Hold	169	–	–	﹤0.01%	1399
2023 Q2	$1.8K	Hold	169	–	–	﹤0.01%	1289
2023 Q1	$1.78K	Hold	169	–	–	﹤0.01%	1281
2022 Q4	$2.09K	Hold	169	–	–	﹤0.01%	1247
2022 Q3	$2K	Hold	169	–	–	﹤0.01%	1231
2022 Q2	$2K	Hold	169	–	–	﹤0.01%	1249
2022 Q1	$2K	Hold	169	–	–	﹤0.01%	1236
2021 Q4	$2K	Sell	169 -15	-8%	-$184	﹤0.01%	1208
2021 Q3	$2K	Buy	184 +15	+9%	+$194	﹤0.01%	1180
2021 Q2	$2K	Hold	169	–	–	﹤0.01%	1148
2021 Q1	$2K	Hold	169	–	–	﹤0.01%	1103
2020 Q4	$2K	Hold	169	–	–	﹤0.01%	1079
2020 Q3	$2K	Buy	169 +99	+141%	+$984	﹤0.01%	1006
2020 Q2	$1K	Hold	70	–	–	﹤0.01%	1046
2020 Q1	$1K	Hold	70	–	–	﹤0.01%	903
2019 Q4	$1K	Hold	70	–	–	﹤0.01%	950
2019 Q3	$1K	Hold	70	–	–	﹤0.01%	853
2019 Q2	$1K	Sell	70 -14	-17%	-$157	﹤0.01%	866
2019 Q1	$1K	Buy	+84	New	+$938	﹤0.01%	823

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Glassman Wealth Services's IRWD Position: Q1 2024 in Review

Glassman Wealth Services sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 169 shares — an estimated $1.93K sold.

Glassman Wealth Services first reported a position in IRWD in Q1 2019 and held it in 20 quarters. The position peaked at $2.09K in Q4 2022. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

Glassman Wealth Services reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 169 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $1.93K.
Glassman Wealth Services first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 20 quarters.
Glassman Wealth Services's Ironwood Pharmaceuticals position peaked at $2.09K in Q4 2022.
261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.